Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals
(AUPH)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Lupkynis
Voclosporin
2021-01-22
2023-2037
Lupus nephritis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Voclosporin
drug interactions
,
eye diseases
,
kidney diseases
,
covid-19
,
focal segmental glomerulosclerosis
,
systemic lupus erythematosus
,
lupus nephritis
,
nephritis
,
uveitis
,
keratoconjunctivitis sicca
,
dry eye syndromes
,
kidney transplantation
,
psoriasis
,
panuveitis
,
keratoconjunctivitis
,
intermediate uveitis
,
posterior uveitis
,
pars planitis
,
syndrome
,
chronic disease
,
anterior uveitis
,
iridocyclitis
,
immunosuppression therapy
,
coronary artery disease
Mycophenolate sodium
leukemia
,
myelodysplastic syndromes
,
myeloid leukemia acute
,
non-hodgkin lymphoma
,
multiple myeloma
,
lymphoma
,
precursor cell lymphoblastic leukemia-lymphoma
,
b-cell chronic lymphocytic leukemia
,
bcr-abl positive chronic myelogenous leukemia
,
hodgkin disease
,
t-cell lymphoma peripheral
,
myeloid leukemia
,
lymphoid leukemia
Mycophenolic acid
systemic scleroderma
,
connective tissue diseases
,
skin diseases
,
diffuse scleroderma
Bevifimod
type 1 diabetes mellitus
,
graft rejection
,
alpha 1-antitrypsin deficiency
,
emphysema
,
pulmonary emphysema
,
graft vs host disease
Nepidermin
hypercholesterolemia
,
dyslipidemias
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use